Ireland leads the way in exciting new Lung Cancer Trial

While the drug was not compared to other medicines or placebo -- a higher standard of clinical trial -- the results marked the first overall survival data from the exciting new drug.
Crizotinib has been FDA approved in the U.S. for the treatment of Lung Cancer. Pifzer received FDA approval of XALKORI® (crizotinib) capsules – the first and only therapy specifically for patients with locally advanced or metastatic non-small cell lung cancer.